An investigation for investors in Retrophin, Inc. (NASDAQ: RTRX) shares over potential securities laws violations by Retrophin, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 11/05/2018 -- An investigation was announced concerning potential securities laws violations by Retrophin, Inc. in connection with certain financial statements.
Investors who purchased shares of Retrophin, Inc. (NASDAQ: RTRX), have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Retrophin, Inc. (NASDAQ: RTRX regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
San Diego, CA based Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of rare diseases. Retrophin, Inc. reported that its annual Total Revenue rose from $133.59 million in 2016 to $154.93 million in 2017 and that its Net Loss increased from $47.9 million in 2016 to $59.73 million in 2017.
Shares of Retrophin, Inc. (NASDAQ: RTRX) closed on November 2, 2018 at $25.80 per share.
Those who purchased shares of Retrophin, Inc. (NASDAQ: RTRX) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels